SCHEMBL8286445

SCHEMBL8286445

Cc1cc(NC(=O)Nc2ccccc2)c2c(=O)cc(Nc3ccccc3)n(-c3ccccc3)c2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.46
KCNJ6 P48051 1/20 0.46
KCNJ5 P48544 1/20 0.46
KCNJ3 P48549 1/20 0.46
PDE11A Q9HCR9 1/20 0.44
SLC2A1 P11166 1/20 0.43
KDM4E B2RXH2 5/20 0.42
MAPT P10636 4/20 0.42
THRB P10828 1/20 0.42
RECQL P46063 1/20 0.42
IGF1R P08069 1/20 0.41
NTRK1 P04629 3/20 0.41
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
ALDH1A1 P00352 2/20 0.40
LMNA P02545 2/20 0.40
GAA P10253 2/20 0.40
HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286452 0.89 PDE11A (0.44) PDE11AKDM4EMAPTMEN1KMT2A
SCHEMBL8285238 0.88 PDE11A (0.49) PDE11AKDM4EMAPTMEN1KMT2A
SCHEMBL8287405 0.86 OPRK1 (0.53) TSHRKCNJ6KCNJ5KCNJ3PDE11A
SCHEMBL8287830 0.86 PDE11A (0.48) TSHRPDE11AKDM4EMAPTMEN1
SCHEMBL8285244 0.84 PDE11A (0.44) TSHRKCNJ6KCNJ5KCNJ3PDE11A
SCHEMBL8286439 0.84 MAPT (0.52) PDE11AKDM4EMAPTMEN1KMT2A
SCHEMBL8285149 0.83 PDE11A (0.47) PDE11AKDM4EMAPTMEN1KMT2A
SCHEMBL8286440 0.82 PDE11A (0.48) PDE11AKDM4EMAPTMEN1KMT2A
SCHEMBL8285163 0.82 POLB (0.50) TSHRPDE11AKDM4EMAPTMEN1
SCHEMBL8285359 0.81 KDM4E (0.47) TSHRKCNJ6KCNJ5KCNJ3PDE11A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed